Location History:
- Kakogawa, JP (1991)
- Takasago, JP (1996 - 2004)
- Takamatsu, JP (2006 - 2008)
Company Filing History:
3 out of 1,705 
2 out of 698 
1 out of 303 
Years Active: 1991-2008
Title: Kenji Yamashita: Innovator in Tissue Regeneration and Hematology
Introduction
Kenji Yamashita is a prominent inventor based in Takamatsu, Japan. He has made significant contributions to the fields of tissue regeneration and hematology, holding a total of 5 patents. His innovative work has the potential to impact medical treatments and improve patient outcomes.
Latest Patents
One of Kenji Yamashita's latest patents is focused on a support for tissue regeneration and the process for producing the same. This invention provides a scaffold that allows cells to be stably retained and grafted in a uniform distribution state during culture. It ensures preferable proliferation ability and viability, particularly in cartilage applications, where fixation treatment can be performed during transplantation. The scaffold is designed to withstand weighted compression at the initial stage of transplantation. Additionally, the invention includes a 3-dimensional porous scaffold that enhances cell seeding properties through various treatments, leading to improved tissue formation and medical treatment effects.
Another notable patent involves a monoclonal antibody and its immunoreactive fragment, which targets a novel HSCA-3 antigen found in immature hemopoietic stem cells. This invention aims to facilitate the immunoassay or flow cytometry processes and assist in the isolation and purification of immature hemopoietic stem cells from human sources.
Career Highlights
Throughout his career, Kenji Yamashita has worked with reputable companies such as Kaneka Corporation and Kanegafuchi Kagaku Kogyo Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Kenji has collaborated with notable coworkers, including Takeshi Fukuchi and Tetsu Kakutani. Their combined efforts have further advanced the research and development of medical technologies.
Conclusion
Kenji Yamashita's contributions to tissue regeneration and hematology through his patents demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly enhance treatment options for patients.